You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (74)

Journals (0)

1-10 of 74 results for EGFR-mutant lung cancer

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer

Open access

Review article

First published 2022

Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer

Jiyun Lee, Zofia Piotrowska, Ross Soo [...]

Therapeutic Advances in Medical Oncology

Select article: Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib

Open access

Review article

First published 2009

Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib

Yoichi Naito, Koichi Goto

Clinical Medicine Insights: Therapeutics

Select article: Application of immune checkpoint inhibitors in EGFR-mutant non-small-cell lung cancer: from bed to bench

Open access

Review article

First published 2020

Application of immune checkpoint inhibitors in EGFR-mutant non-small-cell lung cancer: from bed to bench

Rui Jin, Jing Zhao, Lexin Xia [...]

Therapeutic Advances in Medical Oncology

Select article: Role of radiotherapy in the treatment of EGFR -mutant non-small-cell lung cancer: a narrative review

Open access

Review article

First published 2026

Role of radiotherapy in the treatment of EGFR -mutant non-small-cell lung cancer: a narrative review

Qian Wang, Fengxin Sun, Meng Wu [...]

Therapeutic Advances in Medical Oncology

Select article: Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer

Free access

Research article

First published 2016-4

Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer

Nils D. Arvold, Pedram Heidari, Anchisa Kunawudhi [...]

Technology in Cancer Research & Treatment

Select article: Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients

Open access

Research article

First published 2020-4

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients

Liwen Xiong, Yuqing Lou, Hao Bai [...]

Journal of International Medical Research

Select article: MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process

Free access

Research article

First published 2020-8

MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process

Hsin-Yi Wang, Yi-Nan Liu, Shang-Gin Wu [...]

Cancer Biomarkers

Select article: Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs

Open access

Research article

First published 2023

Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs

Ya Zeng, Xi Su, Yang Zhao [...]

Therapeutic Advances in Medical Oncology

Select article: The Impact of Baseline Vitamin D Level in Patients Receiving Gefitinib-Directed Therapy for EGFR-Mutant Non–Small-Cell Lung Cancer

Open access

Research article

First published 2024

The Impact of Baseline Vitamin D Level in Patients Receiving Gefitinib-Directed Therapy for EGFR-Mutant Non–Small-Cell Lung Cancer

Vanita Noronha, Manali Kolkur, R ArunKumar [...]

Clinical Medicine Insights: Oncology

Select article: Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis

Open access

Research article

First published 2019

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis

Zhonghan Zhang, Kangmei Zeng, Shen Zhao [...]

Therapeutic Advances in Medical Oncology

1
2
3
•••
8
10 / page

Article type

Publication date

Subjects

Access